Press Release | BioActor receives grant from LIOF and Provincie Limburg for the BrainWave project

MAASTRICHT, February 27, 2018

BioActor recently started the BrainWave project, a 12 months project which is financially supported by a grant from LIOF and PROVINCIE LIMBURG. LIOF has initiated the Limburg Business Development Fund, an investment fund that provides knowledge, networking and financial support to reach Proof of Principle for promising innovations with business potential.

BrainWave aims to develop new nutritional solutions to support cognitive performance in middle aged adults. The project has two main thrusts; (i) screening for the candidate nutritional substances with the potential to modulate the mitochondrial respiration and performance; (ii) and to study the most promising candidate substance in a placebo-controlled clinical study. The clinical study will moreover focus on the link between cognitive performance and brain perfusion. The BrainWave project will be run in close collaboration with NUTRIM, the nutrition and health faculty of Maastricht University.

BioActor has built a portfolio of innovative active ingredients for a wide application of use. The active ingredients vary from sports nutrition and active living to healthy aging and bone/gut health. More information about the products of BioActor can be obtained at www.bioactor.com

 

About BioActor:

BioActor, based in Maastricht, Netherlands, is a product development company that supplies proprietary Active Nutritional ingredients to the nutrition & healthcare industry. The company focuses on the development of innovative ANI’s that address the metabolic syndrome and ageing related chronic health conditions. The goal is to provide the nutrition & healthcare industry with science-based innovations that confer a real health benefit to the consumer.

 

For further information, please contact:

BIOACTOR, Hans van der Saag, CEO

Tel :  + 31 6 1173 4108

E-mail : hans.vandersaag@BIOACTOR.com

www.bioactor.com